ADS-5102

2 stories · following the connections

Business

Adamas Announces Publication of ADS-5102 Phase 2 Clinical Trial Results in Multiple Sclerosis Journal

By Nasdaq OMXFeb 1, 2018, 9:05 PM UTC

Business

Adamas Announces Publication of ADS-5102 Phase 3 EASE LID Clinical Trial in JAMA Neurology

By Nasdaq OMXJun 12, 2017, 8:01 PM UTC